etoposide has been researched along with Androblastoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhat, RA; Chia, YN; Lim, YK; Yam, KL | 1 |
Fujimoto, A; Ishihara, O; Itoyama, S; Kinoshita, K; Saitou, M; Takeda, S | 1 |
Burke, TW; Gershenson, DM; Levenback, C; Matthews, CM; Morris, M; Wharton, JT | 1 |
Deppe, G; Tomlinson, MW; Treadwell, MC | 1 |
1 review(s) available for etoposide and Androblastoma
Article | Year |
---|---|
Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Sertoli-Leydig Cell Tumor | 1997 |
1 trial(s) available for etoposide and Androblastoma
Article | Year |
---|---|
Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Prospective Studies; Sertoli-Leydig Cell Tumor; Sex Cord-Gonadal Stromal Tumors; Survival Rate | 1996 |
2 other study(ies) available for etoposide and Androblastoma
Article | Year |
---|---|
Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Ovarian Neoplasms; Ovariectomy; Prognosis; Retrospective Studies; Sertoli-Leydig Cell Tumor; Treatment Outcome | 2013 |
[A case of ovarian malignant Sertoli-Leidig cell tumor treated with CBDCA, etoposide and epirubicin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Remission Induction; Sertoli-Leydig Cell Tumor | 1995 |